Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Galderma and Mentor Worldwide, LLC Announce Plans for Aesthetics Collaboration in Canada

Galderma Canada
Posted on: 14 Sep 16

Canada NewsWire

THORNHILL, ON, Sept. 14, 2016

Two World-Class Organizations Redefine 'Partner of Choice' by Joining Forces Delivering Leading Facial Rejuvenation and Breast Augmentation Solutions

THORNHILL, ON, Sept. 14, 2016 /CNW/ - Galderma, a global leader in medical solutions for skin health, and Mentor Worldwide LLC, a global leader in breast aesthetics and reconstruction, today announce plans for a new nationwide collaboration to partner with Canadian surgeons to elevate the patient experience across the innovative aesthetic and corrective brands and offerings of both companies. The two world-class organizations intend to collaborate to redefine what it means to be "partner of choice" for advancing patient outcomes in aesthetic medicines.

Galderma and Mentor will provide a tailored offering to healthcare professionals who have shared patients looking for aesthetic injectable treatments and breast enhancement. Data show up to 33% of women who had injectable treatments also had breast augmentation1.  This collaboration will provide additional value for cosmetic practices by increasing access to a robust range of technologically-advanced and scientifically-proven solutions for facial rejuvenation and breast augmentation.

The collaboration between Galderma and Mentor demonstrates the commitment of both companies to be the partner of choice within the aesthetics industry and emphasizes the shared goal of providing long-term value to healthcare specialists while broadening consumers' access to and awareness of aesthetic treatment options. It is comprised of Galderma's aesthetic brands, including the Restylane® and Emervel®  family of fillers, Dysport® (abobotulinumtoxinA) and Sculptra® Aesthetic, along with Mentor's MemoryGel® Breast Implant portfolio, for the Canadian aesthetics (non-reimbursed) market. Through this uniquely-designed collaboration, the two companies will look for opportunities to leverage market growth strategies to benefit both healthcare providers and consumers.

About Galderma

Dating back to 1961, Galderma is now present in 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with healthcare professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. For more information, visit

About Mentor

Founded in 1969, Mentor is a leading supplier of medical products in more than 100 countries throughout the world. As the world's leading maker of high-quality breast implants for over 40 years, our experience and investment into advanced manufacturing technology results in quality products that medical professionals can rely on.

Mentor – today a member of the Johnson & Johnson family of companies – has always been and continues to partner with surgeons across the world to develop safe, effective and innovative products that meet the ever-increasing demand of the plastic and reconstructive surgery specialty.

For more information, visit or  


1 Bain Consumer Segmentation – 2014.

SOURCE Galderma Canada

PR Newswire

Last updated on: 14/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.